Last reviewed · How we verify
NCT07061054
Netrod-Pilot Study of Renal Denervation With NetrodTM Sixelectrode Radiofrequency RDN System
NA trial testing Netrod™ six-electrode radiofrequency renal denervation system in Uncontrolled Hypertension in 20 participants. Not yet recruiting.
1 March 2027
Quick facts
| Lead sponsor | Shanghai Golden Leaf MedTec Co. Ltd |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 1 April 2026 |
| Primary completion | 1 March 2027 |
| Estimated completion | 1 December 2027 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Netrod™ six-electrode radiofrequency renal denervation system
Conditions studied
- Uncontrolled Hypertension — all drugs for Uncontrolled Hypertension →
Sponsor
Shanghai Golden Leaf MedTec Co. Ltd
Who can join
Adults 18 to 70, any sex, with Uncontrolled Hypertension. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This single-arm, non-randomized, open-label investigation aims to collect safety and efficacy data of the CE-Marked Netrod™ RDN System in treating European patients with primary hypertension in the absence of anti-hypertensive medication.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07061054
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Uncontrolled Hypertension
Currently open trials in the same condition.
- NCT07005050 — Renal Pelvic Denervation Pilot Trial · NA · recruiting
- NCT06610448 — Wearable Evaluation of Ambulatory Readings for Blood Pressure · NA · recruiting
- NCT06926855 — Community Health Workers Reduce Social Barriers That Affect the Health of Patients With High Blood Pressure and Diabetes · NA · active not recruiting
- NCT06344104 — A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or Mo · Phase 3 · active not recruiting
- NCT06938633 — Addressing Medication Non-adherence in Patients With Poorly Controlled Hypertension Using Urine Mass Spectrometry · NA · recruiting
Other Shanghai Golden Leaf MedTec Co. Ltd trials
Trials by the same sponsor.
- NCT07130955 — A Randomized Trial of Six-Channel RF Ablation System for Renal Denervation in Uncontrolled Hypertension and Chronic Kidn · NA · enrolling by invitation
- NCT07273877 — A Real-World Study on the Treatment of Hypertension With Netrod-RDN Renal Artery Radiofrequency Ablation System · enrolling by invitation
- NCT05631561 — Endovascular Denervation for the Treatment of Type 2 Diabetes Mellitus · NA · unknown
- NCT03261375 — To Evaluate Safety and Efficacy of a Radiofrequency Renal Denervation System in Treatment of Essential Hypertension · NA · completed
- NCT04014478 — A Clinical Trial to Evaluate Safety and Efficacy of Endovascualr Denervation in Treatment of Cancer Pain · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07061054 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shanghai Golden Leaf MedTec Co. Ltd
- Last refreshed: 11 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07061054.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing